Chengming Liu

2.1k total citations
84 papers, 1.4k citations indexed

About

Chengming Liu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chengming Liu has authored 84 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 25 papers in Oncology and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chengming Liu's work include Lung Cancer Treatments and Mutations (15 papers), Cancer Immunotherapy and Biomarkers (12 papers) and RNA modifications and cancer (8 papers). Chengming Liu is often cited by papers focused on Lung Cancer Treatments and Mutations (15 papers), Cancer Immunotherapy and Biomarkers (12 papers) and RNA modifications and cancer (8 papers). Chengming Liu collaborates with scholars based in China, United States and Estonia. Chengming Liu's co-authors include Nan Sun, Sufei Zheng, Jie He, Zhiliang Lu, Shuangshuang Mao, Jianbing Huang, Yuanyuan Lei, Ruochuan Zang, Xin‐Feng Wang and Xiaoli Feng and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Cancer Cell.

In The Last Decade

Chengming Liu

80 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chengming Liu China 22 667 487 366 329 202 84 1.4k
Yun Peng China 17 1.1k 1.7× 286 0.6× 251 0.7× 374 1.1× 249 1.2× 65 1.9k
Hossein Safarpour Iran 20 549 0.8× 372 0.8× 122 0.3× 190 0.6× 269 1.3× 65 1.1k
Morten F. Gjerstorff Denmark 23 1.2k 1.7× 439 0.9× 260 0.7× 489 1.5× 565 2.8× 61 1.8k
Meng Zhao China 21 730 1.1× 363 0.7× 166 0.5× 359 1.1× 440 2.2× 65 1.7k
Jordi Berenguer Spain 15 1.2k 1.7× 313 0.6× 249 0.7× 618 1.9× 138 0.7× 25 1.6k
Hong-Wu Xin China 20 796 1.2× 596 1.2× 128 0.3× 413 1.3× 337 1.7× 52 1.6k
Sandrine Dabernat France 22 1.2k 1.9× 389 0.8× 151 0.4× 312 0.9× 74 0.4× 55 1.7k
Grace Choy United States 10 836 1.3× 476 1.0× 257 0.7× 233 0.7× 119 0.6× 11 1.2k
Wengeng Zhang China 20 773 1.2× 482 1.0× 187 0.5× 224 0.7× 116 0.6× 46 1.4k

Countries citing papers authored by Chengming Liu

Since Specialization
Citations

This map shows the geographic impact of Chengming Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengming Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengming Liu more than expected).

Fields of papers citing papers by Chengming Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengming Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengming Liu. The network helps show where Chengming Liu may publish in the future.

Co-authorship network of co-authors of Chengming Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Chengming Liu. A scholar is included among the top collaborators of Chengming Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengming Liu. Chengming Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shao, Yingying, Yang Wang, Haodong Wang, et al.. (2025). Clinicopathological relationship between PM2.5 exposure and acute exacerbations of chronic obstructive pulmonary disease. Ecotoxicology and Environmental Safety. 291. 117846–117846. 3 indexed citations
2.
Li, Xudong, Chengming Liu, Ruibo Hu, et al.. (2025). DEAD-box protein SMA1 activates immunity likely through the formation of nuclear condensates with EDS1 in Arabidopsis. Cell Reports. 44(7). 115895–115895. 1 indexed citations
3.
Yang, Xiang, Zhiwei Fang, Yufen Cao, et al.. (2025). Development and application of a multiple nucleotide polymorphism (MNP)-based molecular identification system for pear cultivars. BMC Plant Biology. 26(1). 15–15.
4.
Gan, Mailin, Chengming Liu, Meng Wang, et al.. (2024). Analysis of genetic evolutionary differences among four Tibetan pig populations in China. Genomics. 116(6). 110950–110950.
5.
Yang, Zhenlin, Bolun Zhou, Wei Guo, et al.. (2024). Genomic characteristics and immune landscape of super multiple primary lung cancer. EBioMedicine. 101. 105019–105019. 6 indexed citations
6.
Xu, Xiaoyang, Ze Wang, Chengming Liu, et al.. (2024). Immune Indicator Changes in Hepatocellular Carcinoma Undergoing TACE Plus ICIs and Anti-VEGF Antibodies/TKIs: A Prognostic Biomarker Analysis. Journal of Hepatocellular Carcinoma. Volume 11. 2019–2032. 1 indexed citations
7.
Liu, Chengming, et al.. (2024). The RNA-seq mapping of Testicular Development after Heat Stress in Sexually Mature Mice. Scientific Data. 11(1). 913–913. 6 indexed citations
8.
Liu, Chengming, Yong Du, Lei Chen, et al.. (2024). Enhanced immunity: the gut microbiota changes in high-altitude Tibetan pigs compared to Yorkshire pigs. Frontiers in Microbiology. 15. 1469253–1469253. 2 indexed citations
9.
Yang, Yaning, et al.. (2024). Abstract 3263: VEGFA mediates traditional EGFR-TKI resistance in non-small cell lung cancer with EGFR exon 20 insertions. Cancer Research. 84(6_Supplement). 3263–3263. 1 indexed citations
11.
Liu, Chengming, Lu Yang, Haiyan Xu, et al.. (2022). Systematic analysis of IL-6 as a predictive biomarker and desensitizer of immunotherapy responses in patients with non-small cell lung cancer. BMC Medicine. 20(1). 187–187. 55 indexed citations
12.
Liu, Chengming, Sufei Zheng, Zhanyu Wang, et al.. (2022). KRAS ‐G12D mutation drives immune suppression and the primary resistance of anti‐PD‐1/PD‐L1 immunotherapy in non‐small cell lung cancer. Cancer Communications. 42(9). 828–847. 99 indexed citations
13.
Liu, Shunchang, et al.. (2022). Primary signet ring cell carcinoma of the lung: A case report. Journal of Clinical Images and Medical Case Reports. 3(10). 1 indexed citations
14.
Jin, Runsen, Chengming Liu, Sufei Zheng, et al.. (2020). Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancer. Cancer Biology and Medicine. 17(3). 768–781. 42 indexed citations
15.
Zheng, Sufei, Zhiliang Lu, Chengming Liu, et al.. (2019). The TGFβ-Induced Long Non-coding RNA TBULC Promotes the Invasion and Migration of Non-small Cell Lung Cancer Cells and Indicates Poor Prognosis. Frontiers in Oncology. 9. 1340–1340. 5 indexed citations
16.
Liu, Chengming, Ya‐Chi Yu, Ting‐Kai Leung, et al.. (2013). Apoptotic toxicity of destruxin B in human non-Hodgkin lymphoma cells. Toxicology in Vitro. 27(6). 1870–1876. 7 indexed citations
17.
Wang, Ying, et al.. (2010). The Chromosomes Observation of Several Rare Germplasm in Litchi and Longan. Acta Horticulturae Sinica. 37(12). 1991–1994. 2 indexed citations
18.
Hu, Youli, et al.. (2010). Construction of a genetic linkage map of litchi with RAPD, SRAP and AFLP.. Acta Horticulturae Sinica. 37(5). 697–704. 5 indexed citations
19.
Yang, Xianghui, et al.. (2009). Genetic diversity in Eriobotrya genus and its closely related plant species using RAPD markers. Guoshu xuebao. 26(1). 55–59. 1 indexed citations
20.
Liu, Chengming, et al.. (2001). Purification of Thuringiensin from Bacillus Thuringiensis Using Calcium Silicate Adsorption and Dibasic Sodium Phosphate Desorption Methods. Journal of The Chinese Institute of Chemical Engineers. 32(6). 537–545. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026